Investigation of follicle stimulating effect of medical cosmetic remedies on the androgen alopecia model in rats

Authors

DOI:

https://doi.org/10.24959/ubphj.19.217

Keywords:

androgenic alopecia, medical cosmetic remedies, Serenoa repens,

Abstract

Topicality. Androgenic alopecia (AA) is a progressive baldness caused by the effect of androgens on the hair follicle (HF) that develops in people with genetic predisposition. One of the important approaches to AA therapy is the cutaneous application of plant remedies containing phytosterols (antiandrogenic action) and flavonoids (capillary protective, vascular stimulating, antioxidant action).

Aim. To study the follicle stimulating activity of a cream-mask and gel-mask with Serenoa repens dry extract (SRDE) and Sophora japonica tincture on the androgenic alopecia model in rats.

Materials and methods. Investigation of follicle stimulating activity of soft medical cosmetic remedies (MCR) on the androgenic alopecia model was carried out. For this, adult male rats were daily injected with intravenous testosterone (0.1 ml/0.01-1.0 mg) during 10 days. Then the developed MCR and the comparative drug (2 % solution of minoxidil) were daily applied on animals’ shaved area for 21 days; the control group – untreated animals. The MCR effectiveness was evaluated by measuring the mass of shaved new rat fur. Also the morphometric analysis results of HF density per unit area of skin samples were considered.

Results and discussion. The obtained results have shown the rat fur mass from the shaved skin of the animals with the cutaneously applied soft MCR significantly exceeded the rat fur mass from untreated animals and was in the same range in comparison to animals treated with the referent drug. Histologic studies have proved the intensity of HF growth restoration in the experimental groups was significantly higher than the control group.

Conclusions. Thus, the developed cream-mask and gel-mask with SRDE and Sophora japonica tincture with cutaneous application showed the evident follicle stimulating effect.

Author Biographies

M. I. Fedorovska, Ivano-Frankivsk National Medical University

Candidate of Sciences in Pharmaцcy, associate professor of the Organization and Economics in Pharmacy and Drug Technology Department

N. P. Polovko, National University of Pharmacy

Doctor of Pharmacy, professor. Head of the Department of Pharmacy-based Technology of Drugs

O. V. Antymys, Ivano-Frankivsk National Medical University

Candidate of Sciences in Medicine, associate professor of the Human Anatomy Department

References

1. Bolotnaya, L. A., & Sarian, E. I. (2017). Hair diseases. Shidnoevropejskij Zurnal Vnutrisnoi Ta Simejnoi Medicini, 2017(1), 31–38. https://doi.org/10.15407/internalmed2017.01.031.

2. Bolotnaya, L. A. (2012). Dermatolohiia ta venerolohiia, 4, 9–16.

3. Yip, L., Rufaut, N., & Sinclair, R. (2011). Role of genetics and sex steroid hormones in male androgenetic alopecia and female pattern hair loss: An update of what we now know. Australasian Journal of Dermatology, 52(2), 81–88. https://doi.org/10.1111/j.1440-0960.2011.00745.x

4. Dawid-Pać, R., Urbańska, M., Dębosz, I., & Nowak, G. (2014). Plants as potential active components in treatment of androgenetic alopecia. Herba Polonica, 60(1), 49–56.https://doi.org/10.2478/hepo-2014-0005

5. Fedorovska, M., Polovko, N., & Leochko, N. (2017). Development of mask-cream technology with herbal substances for the androgenic alopecia treatment. ScienceRise: Pharmaceutical Science, 3 (7), 19–24.https://doi.org/10.15587/2519-4852.2017.103544.

6. Fedorovska, M. I., Polovko, N. P., Chuprii, I. K. (2017). Likuvalno-kosmetychnyi hel dlia mistsevogo zastosuvania pry androhenii alopetsii. Patent 119311, Ukraine.

7. Wessagowit, V., Tangjaturonrusamee, C., Kootiratrakarn, T., Bunnag, T., Pimonrat, T., Muangdang, N., & Pichai, P. (2016). Treatment of male androgenetic alopecia with topical products containingSerenoa repensextract. Australasian Journal of Dermatology, 57(3), 76–82. https://doi.org/10.1111/ajd.12352.

8. Cholak, I. S. (2010). Fitoterapiia. Chasopys, 4, 82–85.

9. Matias, J. R., Malloy, V., & Orentreich, N. (1989). Animal models of androgen-dependent disorders of the pilosebaceous apparatus. Archives of Dermatological Research, 281(4), 247–253. https://doi.org/10.1007/bf00431058.

10. Bahrii, M. M. (2016). Metodyky morfolohichnykh doslidzhen. Vinnytsia «Nova knyha», 295.

Downloads

Published

2019-05-21

Issue

No. 2(59) (2019)

Section

Pharmacology and biochemistry

License

Copyright (c) 2019 National University of Pharmacy

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).